The Effectiveness of a One-stop Electronic Clinic for Psychological Service (eClinic) in Hong Kong
2026年5月14日 更新者：New Life Psychiatric Rehabilitation Association
With an increasing need for effective and accessible mental health services, telepsychology can be one promising solution to narrowing the gap between demand and supply.
Our one-stop electronic clinic of psychological service (eClinic) aims to deliver evidence-based treatments to individuals with moderate to severe emotional disorders of various kinds in Hong Kong.
This study examines the cost-effectiveness and cost-efficiency of a hybrid model of telepsychology, in which contact with therapists focuses on facilitating service users' self-learning based on our online interactive modules.
Results will shed light on the benefits of telepsychology to promoting access to mental health services in Hong Kong.
調査の概要
研究の種類
観察的
入学 (実際)
420
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
Hong Kong
-
Hong Kong、Hong Kong、香港
- New Life Psychiatric Rehabilitation Association
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
- 子
- 大人
健康ボランティアの受け入れ
いいえ
サンプリング方法
非確率サンプル
調査対象母集団
Individuals aged between 15 and 35 years that are able to speak, read, and write Chinese, and present with moderate to severe depression or anxiety at the time of intake.
説明
Inclusion Criteria:
- Screened eligible for and enrolled in the eClinic service
- Age between 15 and 35 years
- Speak, read, and write Chinese
- Present with moderate to severe depression (i.e., Patient Health Questionnaire-9 (PHQ-9) total score ≥ 10) or anxiety (i.e., Generalized Anxiety Disorder-7 (GAD-7) total score ≥ 8)
Exclusion Criteria:
- Present with a history of psychosis in the recent 2 years
- Present with severe risk for self-harm/suicide (i.e., indicated as being at higher risk on the P4 suicidality screener during the service-related screening procedure prior to enrollment in the eClinic service)
- Present with active homicidal ideations (i.e., assessed during the service-related screening procedure prior to enrollment in the eClinic service)
- Demonstrate sub-average intelligence (e.g., based on a history of intellectual disability)
- Concurrently receive other psychological services
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Patient Health Questionnaire-9 (PHQ-9)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The PHQ-9 measures the presence of depressive symptoms in the recent two weeks.
The scale measures the nine diagnostic criteria of major depressive disorder on a scale from 0 = not at all to 3 = nearly every day, according to Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV).
Total score on the PHQ-9 ranges from 0 to 27, with higher scores indicating higher distress.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Generalized Anxiety Disorder-7 (GAD-7)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The GAD-7 assesses Generalized Anxiety Disorder (GAD) symptoms in the recent two weeks.
It consists of 7 items, each rated on a 4-point Likert scale from 0 = not at all to 3 = nearly every day.
Total score on the GAD-7 ranges from 0 to 21.
A higher GAD-7 score indicates more severe impairment related to GAD symptoms.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Brief Experiential Avoidance Questionnaire (BEAQ)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The 15-item BEAQ assesses several domains of experiential avoidance.
Items are rated on a 6-point Likert scale of 1 = strong disagree to 6 = strong agree.
Total score of the BEAQ ranges from 15 to 90, with a higher score representing greater experiential avoidance.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Difficulties in Emotion Regulation Scale-16 (DERS-16)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The DERS-16 assesses level of difficulties with emotion regulation.
Each of the 16 items is rated on a 5-point Likert scale of 1 = almost never to 5 = almost always, with a total score ranges from 16 to 80.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Cognitive Distortions Questionnaire (CD-Quest)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The CD-Quest is a self-report measure that contains 15 bi-dimensional items that measure the frequency and intensity of 15 cognitive distortions.
For each type of cognitive distortions, participants indicate if it has occurred or not; for any occurrence, individuals rate the frequency and intensity of the cognitive distortion on a 3x3 grid.
Therefore, score on each item ranges from 0 = no (it did not occur) to 5 = occurs almost all the time and with an intensity of more than 70%.
Total score of the CD-Quest ranges from 0 to 75, with a higher score representing a higher frequency and intensity of cognitive distortions.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Cognitive Flexibility Inventory (CFI)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The CFI is a self-report measure of cognitive flexibility.
20 items of the CFI are rated on a 7-point Likert scale of 1 (strongly disagree) to 7 (strongly agree).
Total score of the CFI ranges from 20 to 140, with higher scores indicating greater cognitive flexibility.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Gratitude Questionnaire-5 (GQ-5)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The GQ-5 is a self-reported instrument that assesses gratitude.
Five items of the GQ-5 are rated on a 7-point Likert scale from 1 = strongly disagree to 7 = strongly agree.
Total score of the GQ-5 ranges from 5 to 35, with higher scores indicating higher level of gratitude.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Penn State Worry Questionnaire (PSWQ)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The PSWQ is a 16-item self-report instrument designed to measure the construct of worry.
Each item is rated on a 5-point Likert scale that ranges from 1 = not at all typical of me to 5 = very typical of me.
Five items are reversely scored to obtain a total score ranges from 16 to 80.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Liebowitz Social Anxiety Scale (LSAS)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The LSAS assesses fear and avoidance related to social anxiety disorder.
The 24-item scale is divided into two broad domains of situations, with 11 items on social anxiety and 13 items on performance fear.
Each of the 24 items is rated on a 4-point Likert scale of 0 = none to 3 = severe for anxiety items or usually for avoidance items.
The total score of LSAS ranges from 0 to 144.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Obsessive-Compulsive Inventory-Revised (OCI-R)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The OCI-R is an 18-item self-report scale for measuring the severity of obsessive-compulsive symptoms.
Each item is rated on a 5-point Likert scale of 0 = not at all to 4 = extremely.
The OCI-R total score ranges from 0 to 72, with higher scores indicating a greater likelihood of OCD.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Posttraumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The PCL-5 is a self-report measure of posttraumatic stress disorder (PTSD) symptom severity, based on its diagnostic criteria in Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5).
Each of the 20 items is rated on a 5-point Likert scale of 0 = not at all to 4 = extremely.
The PCL-5 total score ranges from 0 to 80, with higher scores indicating greater PTSD severity.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Insomnia Severity Index (ISI)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The ISI evaluates the nature, severity, and impact of insomnia.
It consists of 7 items rated on a 5-point Likert scale from 0 = no problem to 4 = very severe problem, with a total score ranging from 0 to 28.
Higher scores on the ISI indicate more severe insomnia.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Short Health Anxiety Inventory (SHAI)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The SHAI is an 18-item self-report measure that assesses an individual's concern about possibly having health illnesses of different kinds, and the catastrophic thinking about having the illnesses.
Total score of the SHAI ranges from 0 to 54, where higher scores indicate greater health anxiety.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Work and Social Adjustment Scale (WSAS)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The WSAS is a 5-item scale that measures self-report severity of impairment across five domains of functioning.
Each item is rated on a 9-point Likert scale of 0 = not at all to 8 = very severely.
Total score of the WSAS ranges from 0 to 40, where higher scores indicate greater functional impairment.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Rosenberg Self-Esteem Scale (RSES)
時間枠：Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The RSE has 10 items that assess self-esteem, each rated on a 4-point Likert scale of 1 = strongly agree to 4 = strongly disagree.
Total score of the RSE ranges from 0 to 30, with lower scores suggesting lower self-esteem.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始 (実際)
2022年12月28日
一次修了 (実際)
2025年10月31日
研究の完了 (実際)
2025年10月31日
試験登録日
最初に提出
2026年5月8日
QC基準を満たした最初の提出物
2026年5月14日
最初の投稿 (実際)
2026年5月20日
学習記録の更新
投稿された最後の更新 (実際)
2026年5月20日
QC基準を満たした最後の更新が送信されました
2026年5月14日
最終確認日
2026年4月1日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。